Relief therapeutics « Terug naar discussie overzicht

Forum Relief therapeutics geopend

2 Posts
IEX - Forummoderator
Relief is a biopharmaceutical company founded by former Merck executives (Serono division) whose objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need.

We focus on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use (well-established safety and tolerability) and either initial human activity with efficacy data (proof-of-concept) or a strong scientific rationale. Our most advanced programs involve our lead compound RLF-100™, a synthetic human vasoactive intestinal peptide (VIP) with multifaceted mode of action, in respiratory indications: COVID-19 induced lung injury with major near-term milestones and pulmonary sarcoidosis, two diseases for which no transformational therapy exists. Clinical development of RLF-100™ for other indications in both acute and chronic lung diseases are in planning stages.

Groet Henk
Dag Henk,
Relief Therapeutics Holding AG juni 2020 is een bestaand forum .
Komt er een pré en post EUA ;-)
Of is dit het forum voor de ZWR alleen ?

2 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum


Vertraagd 2 jun 2023 17:30
Koers 3,840
Verschil +0,040 (+1,05%)
Hoog 3,890
Laag 3,700
Volume 20.508
Volume gemiddeld 3.483.534
Volume gisteren 28.535

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront